The Department of Biotechnology’s Biotech Consortium India Limited (BCIL) is looking for an industrial partner for commercialization of a technology for producing a Bivalent Outer Membrane Vesicles (OMV) vaccine against typhoid. Typhoid fever usually occurs in children aged between 5–15 years.